Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME), a leading provider of AI-powered logistics solutions, today provided a summary of the milestones it achieved during the first half of 2026, and ...
Peer-reviewed preclinical melanoma research finds Provectus’s synthetic small molecule can both stimulate anti-tumor immunity and suppress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results